NBIX

Name: NEUROCRINE BIOSCIENCES INC Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

NEUROCRINE BIOSCIENCES INC

Health Care · Pharmaceuticals

NEUROCRINE BIOSCIENCES INC (NBIX) has 18 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	GORMAN KEVIN CHARLES	620.9K	$79.68M	-
CEO	Gano Kyle	140.4K	$18.02M	-
Other	BENEVICH ERIC	52.8K	$6.77M	-
Other	Lippoldt Darin	46.8K	$6.00M	-
Other	Cooke Julie	26.9K	$3.45M	-

Activity

Buys and sells only

Transactions

10 filings · page 41

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Apr 12, 2017	OBrien Christopher Flint	Chief Medical Officer	Sell	13,065	$50.42	$658,773.93	-11.7%
Apr 12, 2017	Lloyd-Smith Malcolm	Chief Regulatory Officer	Sell	13,065	$50.42	$658,773.93	-33.2%
Apr 12, 2017	Lippoldt Darin	Chief Legal Officer	Sell	13,065	$50.42	$658,773.93	-33.0%
Apr 12, 2017	Grigoriadis Dimitri E.	Chief Research Officer	Sell	13,065	$50.42	$658,773.93	-4.9%
Apr 12, 2017	GORMAN KEVIN CHARLES	Chief Executive Officer	Sell	19,596	$50.42	$988,085.28	-2.9%
Apr 12, 2017	Gano Kyle	Chief Business Development Off	Sell	13,065	$50.42	$658,773.93	-8.2%
Apr 12, 2017	Bozigian Haig P.	Chief Development Officer	Sell	13,065	$50.42	$658,773.93	-4.8%
Feb 7, 2017	Lloyd-Smith Malcolm	Chief Regulatory Officer	Sell	843	$43.35	$36,544.81	-43.8%
Feb 7, 2017	BENEVICH ERIC	Chief Commercial Officer	Sell	953	$43.32	$41,287.11	-43.8%
Feb 7, 2017	Lippoldt Darin	Chief Legal Officer	Sell	953	$43.34	$41,299.57	-43.8%

← PrevPage 41Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC